Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study

Helen Gogas, Brigitte Dréno, James Larkin, Lev Demidov, Daniil Stroyakovskiy, Zeynep Eroglu, Pier Francesco Ferrucci, Jacopo Pigozzo, Piotr Rutkowski, Jacek Mackiewicz, Isabelle Rooney, Athina Voulgari, Sarah Troutman, Bethany Pitcher, Guo Yu, Y. Yan, Marília Germanos de Castro, S. Mulla, Keith T. Flaherty, Ana Arance